Why the study?
Does a 30-day smartphone-based intervention with a relational agent and Kardia monitoring improve HRQoL and medication adherence in patients with AF?
Does a 30-day smartphone-based intervention with a relational agent and Kardia monitoring improve HRQoL and medication adherence in patients with AF?
A 30-day smartphone-based intervention with a relational agent and Kardia monitoring showed favorable improvements in HRQoL and medication adherence in AF patients, supporting a future randomized trial.
Pilot results justify a definitive RCT in AF; should not yet influence clinical decisions on digital interventions.
We piloted a 30-day smartphone-based intervention that combined a relational agent with dedicated content for AF alongside Kardia heart rate and rhythm monitoring. Pilot participants had favorable improvements in HRQoL and self-reported medication adherence, as well as positive responses to the intervention. These data will guide a larger, enhanced randomized trial implementing the smartphone relational agent and the Kardia monitor system.
No takes yet. Share an insight, caveat, or question.
Magnani et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: